Revolution Medicines is seeking an Executive Director to lead the development and execution of global market access and pricing strategies for assets in the key disease area of NSCLC. The role will work closely with regions to build resources to support optimal access to these assets.
Requirements
- Formulate and define asset and disease area pricing and reimbursement strategies
- Craft a differentiated global value proposition
- Work closely with members of the Disease Area Strategy teams
- Design and implement strategic plans to support clinical development programs
- Identify and assess global market access risks and opportunities
- Partner with Clinical Development and Regulatory Affairs
- Collaborate closely with the HEOR team
- Engage with Regions to incorporate payer, policy insights and global trends
- Lead global payer research and work with regions to gain actionable early engagement/advice from key HTA bodies
- Prepare and submit HTA and reimbursement dossiers in priority markets
- Partner with Medical Affairs, HEOR, Regulatory, and Clinical
- Build strong cross-funtional relations and build a high-performing team
- Represent the company externally with payers, HTA bodies, trade associations, and policy groups
Benefits
- Competitive cash compensation
- Robust equity awards
- Strong benefits
- Significant learning and development opportunities